The added benefit of BITEs involves the upregulation of multiple T-cell compartments, both CD4+ and CD8+, leading not only to myeloma cell lysis but also differentiation of naïve T cells into memory T cells as well [73]. The gene discussed is CD4; the disease is plasma cell myeloma.